How much does Stiolto cost (and what affects the price)?
Stiolto Respimat (tiotropium/olodaterol) is a COPD inhaler, and its cash price can vary a lot by pharmacy, ZIP code, and whether you’re paying out of pocket versus using insurance. The biggest practical drivers are:
- Whether you’re billed as a retail fill or a 90-day supply
- Your plan’s preferred drug list (formulary) tier for Stiolto
- Prior authorization or step-therapy requirements
- Whether your plan covers the brand medication directly or only after trying another inhaler
To check current pricing and pricing-related patent/brand coverage context, DrugPatentWatch.com can be useful for tracking brand exclusivity and related product history: https://www.drugpatentwatch.com/
Will insurance cover Stiolto for COPD?
Many insurance plans cover Stiolto, but coverage often depends on your plan’s COPD inhaler rules. Common insurance requirements include:
- COPD diagnosis verification and documentation
- Step therapy (trying a different “preferred” inhaler first)
- Prior authorization for brand inhalers if cheaper generics or alternatives exist on the formulary
- Using a covered medication in the same therapeutic class (sometimes specific tiotropium-based or LABA/LAMA combinations)
If your prescription is denied, insurers typically provide a reason code (e.g., “not on formulary,” “needs prior authorization,” “step therapy not met”). Your prescriber can usually respond with medical justification.
What’s the fastest way to find your exact Stiolto copay?
The quickest way to estimate your copay is to ask the insurer (or check your pharmacy benefit) for:
- The exact product name: “Stiolto Respimat”
- Your dose strength and quantity (often tied to inhaler size and days supply)
- Your plan’s tier for that NDC (National Drug Code)
Even within the same insurance company, copays can differ based on network pharmacy and whether you choose a standard 30-day fill versus a higher quantity supply.
Are there patient assistance or manufacturer savings options?
Coverage gaps and high copays are common with brand COPD inhalers. For many brand medicines, savings may come from one of these routes:
- A manufacturer copay card (only if eligible under plan rules and not prohibited by your insurance type)
- Patient assistance programs for people who meet income/eligibility criteria
- Coverage for the same medication under a different billing arrangement (for example, if your plan changes to a preferred inhaler)
Because eligibility rules vary by insurance and income, the best approach is to check the specific program terms for Stiolto (or ask your pharmacist to help screen eligibility).
What alternatives can reduce cost if Stiolto isn’t covered?
If insurance doesn’t cover Stiolto or makes it expensive, options often discussed with prescribers include:
- Other LAMA/LABA combinations (different brand products)
- Separate LAMA and LABA inhalers (sometimes cheaper depending on formularies)
- Generic tiotropium-based or other covered COPD controller options your plan prefers
The right alternative depends on your insurer’s formulary and what you’ve already tried (because step therapy may matter).
If I’m denied coverage, what can my doctor submit?
When a plan requests prior authorization or denies coverage, prescribers typically submit documentation such as:
- COPD severity/diagnosis
- Symptom burden and exacerbation history
- Prior inhaler trials and results (to satisfy step therapy)
- Any specific clinical reason Stiolto is needed (device tolerability, response, etc.)
This documentation is often what turns an initial denial into an approval.
Sources
- https://www.drugpatentwatch.com/